92 related articles for article (PubMed ID: 17487556)
1. Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.
Zhu S; Gladson CL; White KE; Ding Q; Stewart J; Jin TH; Chapman HA; Olman MA
Am J Physiol Lung Cell Mol Physiol; 2009 Jul; 297(1):L97-108. PubMed ID: 19411312
[TBL] [Abstract][Full Text] [Related]
2. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Montuori N; Bifulco K; Carriero MV; La Penna C; Visconte V; Alfano D; Pesapane A; Rossi FW; Salzano S; Rossi G; Ragno P
Cell Mol Life Sci; 2011 Jul; 68(14):2453-67. PubMed ID: 20972812
[TBL] [Abstract][Full Text] [Related]
3. K
Ohya S; Kajikuri J; Endo K; Kito H; Matsui M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948357
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells.
Jevnikar Z; Rojnik M; Jamnik P; Doljak B; Fonovic UP; Kos J
J Biol Chem; 2013 Jan; 288(4):2201-9. PubMed ID: 23204516
[TBL] [Abstract][Full Text] [Related]
5. Cellular Invasion Assay for the Real-Time Tracking of Individual Cells in Spheroid or Tumor-like Mimics.
Kenney RM; Lee MC; Boyce MW; Sitte ZR; Lockett MR
Anal Chem; 2023 Feb; 95(5):3054-3061. PubMed ID: 36701161
[TBL] [Abstract][Full Text] [Related]
6. Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells.
Hubbard SC; Boyce M; McVaugh CT; Peehl DM; Bertozzi CR
Bioorg Med Chem Lett; 2011 Sep; 21(17):4945-50. PubMed ID: 21798741
[TBL] [Abstract][Full Text] [Related]
7.
Mukherjee A; Park A; Davies KP
J Mens Health; 2022 Feb; 18(2):. PubMed ID: 35547856
[TBL] [Abstract][Full Text] [Related]
8. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.
Thakkar A; Aljameeli A; Thomas S; Shah GV
Endocr Relat Cancer; 2016 Jan; 23(1):1-14. PubMed ID: 26432469
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.
Milone MR; Pucci B; Bifulco K; Iannelli F; Lombardi R; Ciardiello C; Bruzzese F; Carriero MV; Budillon A
Oncotarget; 2015 Mar; 6(7):5324-41. PubMed ID: 25481874
[TBL] [Abstract][Full Text] [Related]
10. RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.
Sutherland M; Gordon A; Shnyder SD; Patterson LH; Sheldrake HM
Cancers (Basel); 2012 Oct; 4(4):1106-45. PubMed ID: 24213501
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
[TBL] [Abstract][Full Text] [Related]
12. Role of integrins in regulating proteases to mediate extracellular matrix remodeling.
Yue J; Zhang K; Chen J
Cancer Microenviron; 2012 Dec; 5(3):275-83. PubMed ID: 22437309
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.
Shah GV; Muralidharan A; Thomas S; Gokulgandhi M; Mudit M; Khanfar M; El Sayed K
Mol Cancer Ther; 2009 Mar; 8(3):509-20. PubMed ID: 19276166
[TBL] [Abstract][Full Text] [Related]
14. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
Thomas S; Chigurupati S; Anbalagan M; Shah G
Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
[TBL] [Abstract][Full Text] [Related]
17. Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.
Thomas S; Muralidharan A; Shah GV
Int J Oncol; 2007 Dec; 31(6):1425-37. PubMed ID: 17982669
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
[TBL] [Abstract][Full Text] [Related]
19. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
